Tremeau Pharmaceuticals is Pharmaceuticals in United States that focus on clinical-stage product business. Founded in 2016. They cover business area such as Provider, non-opioid pain therapy, well-define patient population, significant unmet need, (rofecoxib, an approach, acute and chronic pain, select condition, action, document efficacy.
2016
( 10 years old in 2026 )
Clinical-stage Product
-
53 Main Street
Suite 202
Concord, MA 01742
United States
Private
Providernon-opioid pain therapywell-define patient populationsignificant unmet need(rofecoxiban approachacute and chronic painselect conditionactiondocument efficacy
* We use standard office opening hours in near Tremeau Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Tremeau Pharmaceuticals is Pharmaceuticals business from United States that founded in 2016 (10 years old in 2026), Tremeau Pharmaceuticals business is focusing on Clinical-stage Product.
Tremeau Pharmaceuticals headquarter office and corporate office address is located in 53 Main Street Suite 202 Concord, MA 01742 United States.
Tremeau Pharmaceuticals was founded in United States.
In 2026, Tremeau Pharmaceuticals is currently focus on clinical-stage product sector.
Above is snippet of Google Trends for "clinical-stage product" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Tremeau Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
